High Tower Advisors, LLC Dare Bioscience, Inc. Transaction History
High Tower Advisors, LLC
- $61.2 Billion
- Q1 2024
A detailed history of High Tower Advisors, LLC transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 10,800 shares of DARE stock, worth $3,672. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,800
Previous 46,700
76.87%
Holding current value
$3,672
Previous $14,000
64.29%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding DARE
# of Institutions
37Shares Held
6.86MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.45MShares$1.17 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA989KShares$336,3640.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny763KShares$259,3860.0% of portfolio
-
Black Rock Inc. New York, NY396KShares$134,6730.0% of portfolio
-
State Street Corp Boston, MA248KShares$84,2210.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $28.8M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...